Literature Review
Primary Risks of Oral Contraceptives and Hormone Replacement Therapy
by: Gina Cushman, NMD, PhD
Long-term use of oral contraceptives (OCs) and of hormone replacement therapy (HRT) have been linked to increased blood coagulation, with its increased risk of cardiovascular problems. Their long-term use also has been linked to altered immune and inflammatory factors, suggesting an increased risk of chronic immune disorders with an inflammatory component, including cancer. This report reviews these various risks. Also discussed are 2 natural food extracts, one showing anticoagulant effects and the other exhibiting certain anti-inflammatory and immunomodulatory effects. New research finds indications that these extracts—Plasmanex1 and BRM4—offset these key risks among OC and HRT users and suggests the need for further research.
Read
Sponsored Podcast
Exploring Hepatoprotective Herbs
Interview With Tori Hudson, ND
Tori Hudson, ND, describes the clinical application of several herbs used to support liver health. She focuses specifically on milk thistle, turmeric, Chinese skullcap, licorice, and schisandra.
Read More
Interview With an Expert
Progress and Challenges in Research
Interview with Dugald Seely, ND, FABNO
Dugald Seely, ND, FABNO, founding director of the Ottawa Integrative Cancer Centre (OICC) talks about past research and future plans for research in naturopathic oncology.
ted